Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway
Section of Throacic Oncology, Surgery Branch, Center for Cancer Research, National Cancer Center, National Institutes of Health, Bethesda, MD, USA. Dao_Nguyen@nih.gov